• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于血红蛋白的氧载体(HBOC-201)对择期腹主动脉手术术前进行血液稀释的患者血流动力学和氧输送的影响。

Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery.

作者信息

Kasper S M, Walter M, Grüne F, Bischoff A, Erasmi H, Buzello W

机构信息

Department of Anesthesiology, University of Cologne, Germany.

出版信息

Anesth Analg. 1996 Nov;83(5):921-7.

PMID:8895264
Abstract

We conducted a pilot study to evaluate the effects of HBOC-201, a bovine hemoglobin-based oxygen carrier, on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. After induction of anesthesia and isovolemic hemodilution with 1 L of lactated Ringer's solution, 13 patients were randomly assigned to receive, within 30 min, 3 mL/kg of either HBOC-201 or 6% hydroxyethyl starch (HES). Monitored variables included invasive arterial and pulmonary artery pressures, arterial and mixed venous blood gases, and calculations of cardiac index (CI), systemic and pulmonary vascular resistance indices, oxygen delivery index (DO2I), oxygen consumption index (VO2I), and oxygen extraction ratio (O2ER). Thirty minutes after HBOC-201 infusion, mean arterial pressure, systemic vascular resistance index, and CI were 149% (P = 0.028), 169% (P = 0.046), and 75% (P = 0.46) of the preinfusion values, respectively. No significant changes were noticed in heart rate and pulmonary vascular resistance index. DO2I and VO2I, 30 min after the infusion of HBOC-201, were 79% (P = 0.046) and 76% (P = 0.028) of the preinfusion values, respectively, whereas CaO2 and O2ER remained unaffected. We conclude that HBOC-201, at a dose of 3 mL/kg, impairs oxygen delivery because of adverse effects on cardiac output.

摘要

我们进行了一项初步研究,以评估基于牛血红蛋白的氧载体HBOC-201对接受择期腹主动脉手术术前血液稀释患者的血流动力学和氧输送的影响。在麻醉诱导并用1升乳酸林格氏液进行等容血液稀释后,13名患者被随机分配在30分钟内接受3 mL/kg的HBOC-201或6%羟乙基淀粉(HES)。监测变量包括有创动脉压和肺动脉压、动脉血和混合静脉血气,以及心指数(CI)、全身和肺血管阻力指数、氧输送指数(DO2I)、氧消耗指数(VO2I)和氧摄取率(O2ER)的计算。输注HBOC-201后30分钟,平均动脉压、全身血管阻力指数和CI分别为输注前值的149%(P = 0.028)、169%(P = 0.046)和75%(P = 0.46)。心率和肺血管阻力指数无显著变化。输注HBOC-201后30分钟,DO2I和VO2I分别为输注前值的79%(P = 0.046)和76%(P = 0.028),而CaO2和O2ER保持不变。我们得出结论,剂量为3 mL/kg的HBOC-201由于对心输出量有不利影响而损害氧输送。

相似文献

1
Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery.一种基于血红蛋白的氧载体(HBOC-201)对择期腹主动脉手术术前进行血液稀释的患者血流动力学和氧输送的影响。
Anesth Analg. 1996 Nov;83(5):921-7.
2
The effects of increased doses of bovine hemoglobin on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery.
Anesth Analg. 1998 Aug;87(2):284-91. doi: 10.1097/00000539-199808000-00009.
3
Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.高渗高渗胶体溶液可改善儿童心脏直视手术后的心脏功能。
Pediatrics. 2006 Jul;118(1):e76-84. doi: 10.1542/peds.2005-2795. Epub 2006 Jun 2.
4
[Preoperative hemodilution with bovine hemoglobin. Acute hemodynamic effects in liver surgery patients ].[牛血红蛋白术前血液稀释。对肝脏手术患者的急性血流动力学影响]
Anaesthesist. 1997 Sep;46(9):763-70. doi: 10.1007/s001010050466.
5
Enhanced central organ oxygenation after application of bovine cell-free hemoglobin HBOC-201.应用牛无细胞血红蛋白HBOC - 201后增强了中枢器官氧合作用。
Can J Anaesth. 2005 Nov;52(9):904-14. doi: 10.1007/BF03022050.
6
Comparison of hemodynamic changes after acute normovolemic hemodilution using Ringer's lactate versus 5% albumin in patients on beta-blockers undergoing coronary artery bypass surgery.在接受冠状动脉搭桥手术的β受体阻滞剂治疗患者中,比较使用乳酸林格氏液与5%白蛋白进行急性等容血液稀释后的血流动力学变化。
J Cardiothorac Vasc Anesth. 2006 Dec;20(6):812-8. doi: 10.1053/j.jvca.2005.04.012. Epub 2006 Jan 6.
7
Arterial oxygenation and oxygen delivery after hemoglobin-based oxygen carrier infusion in canine hypovolemic shock: a dose-response study.基于血红蛋白的氧载体输注对犬失血性休克动脉氧合及氧输送的影响:剂量反应研究
Crit Care Med. 2003 Jun;31(6):1771-9. doi: 10.1097/01.CCM.0000063476.79749.C1.
8
A hemoglobin-based oxygen carrier, bovine polymerized hemoglobin (HBOC-201) versus hetastarch (HEX) in a moderate severity hemorrhagic shock swine model with delayed evacuation.在一个伴有延迟后送的中度失血性休克猪模型中,基于血红蛋白的氧载体牛聚合血红蛋白(HBOC - 201)与贺斯(羟乙基淀粉)的比较。
Resuscitation. 2005 Sep;66(3):367-78. doi: 10.1016/j.resuscitation.2005.03.019.
9
Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans.基于血红蛋白的氧载体可维持人类次最大运动能力。
Clin Pharmacol Ther. 1995 Oct;58(4):434-43. doi: 10.1016/0009-9236(95)90057-8.
10
Bovine polymerized hemoglobin versus Hextend resuscitation in a swine model of severe controlled hemorrhagic shock with delay to definitive care.在严重控制性失血性休克且延迟确定性治疗的猪模型中,牛聚合血红蛋白与Hextend复苏效果的比较
Shock. 2006 Sep;26(3):302-10. doi: 10.1097/01.shk.0000226338.48033.c2.

引用本文的文献

1
Hemoglobin-based oxygen carriers, oxidative stress and myocardial infarction.基于血红蛋白的氧载体、氧化应激与心肌梗死
Front Physiol. 2025 Apr 15;16:1551932. doi: 10.3389/fphys.2025.1551932. eCollection 2025.
2
Artificial Blood: A Futuristic Dimension of Modern Day Transfusion Sciences.人造血液:现代输血科学的未来维度。
Cardiovasc Hematol Agents Med Chem. 2019;17(1):11-16. doi: 10.2174/1871525717666190617120045.
3
Haemoglobin-based oxygen carriers: research and reality towards an alternative to blood transfusions.
基于血红蛋白的氧载体:关于输血替代品的研究与现状
Blood Transfus. 2010 Jun;8 Suppl 3(Suppl 3):s59-68. doi: 10.2450/2010.010S.
4
Intravenous fluids for abdominal aortic surgery.腹主动脉手术用静脉输液。
Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD000991. doi: 10.1002/14651858.CD000991.pub2.
5
A review of blood substitutes: examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers.血液代用品综述:考察血红蛋白基氧载体的历史、临床试验结果和伦理学。
Clinics (Sao Paulo). 2009;64(8):803-13. doi: 10.1590/S1807-59322009000800016.
6
The USA Multicenter Prehosptial Hemoglobin-based Oxygen Carrier Resuscitation Trial: scientific rationale, study design, and results.美国多中心基于血红蛋白的氧载体院前复苏试验:科学依据、研究设计与结果。
Crit Care Clin. 2009 Apr;25(2):325-56, Table of Contents. doi: 10.1016/j.ccc.2009.01.002.
7
Decreased damage from transient focal cerebral ischemia by transfusion of zero-link hemoglobin polymers in mouse.小鼠输注零连接血红蛋白聚合物可减轻短暂性局灶性脑缺血损伤。
Stroke. 2009 Jan;40(1):278-84. doi: 10.1161/STROKEAHA.108.526731. Epub 2008 Nov 6.
8
Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis.基于无细胞血红蛋白的血液替代品与心肌梗死和死亡风险:一项荟萃分析。
JAMA. 2008 May 21;299(19):2304-12. doi: 10.1001/jama.299.19.jrv80007. Epub 2008 Apr 28.
9
Hemoglobin-based oxygen carriers in trauma care: scientific rationale for the US multicenter prehosptial trial.创伤救治中基于血红蛋白的氧载体:美国多中心院前试验的科学依据
World J Surg. 2006 Jul;30(7):1247-57. doi: 10.1007/s00268-005-0499-6.
10
Dependence of acetylcholine and ADP dilation of pial arterioles on heme oxygenase after transfusion of cell-free polymeric hemoglobin.无细胞聚合血红蛋白输注后软脑膜小动脉乙酰胆碱和ADP扩张对血红素加氧酶的依赖性
Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H1027-37. doi: 10.1152/ajpheart.00500.2005. Epub 2005 Oct 7.